- |||||||||| Journal: The bioelectrical impedance analysis and sarcopenia: Devices (Pubmed Central) - Mar 2, 2024
Older age, higher education, poor exercise habits, hypoproteinemia, hypertension, and total gastrectomy are risk factors for its development post-radical gastrectomy. No abstract available
- |||||||||| Trial completion date, Trial initiation date, Trial primary completion date: COOLEY- Study: ACute on ChrOnic Liver FailurE Using the CYtosorb Device (clinicaltrials.gov) - Mar 2, 2024
P=N/A, N=20, Not yet recruiting, Trial primary completion date: Dec 2023 --> Aug 2024 Trial completion date: Jun 2026 --> Jun 2027 | Initiation date: Jan 2024 --> Apr 2024 | Trial primary completion date: Dec 2025 --> Apr 2026
- |||||||||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Trial completion date, Trial initiation date, Trial primary completion date: SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY (clinicaltrials.gov) - Mar 2, 2024 P=N/A, N=1000, Not yet recruiting, Trial completion date: Jun 2026 --> Jun 2027 | Initiation date: Jan 2024 --> Apr 2024 | Trial primary completion date: Dec 2025 --> Apr 2026 Trial completion date: Sep 2025 --> Apr 2026 | Initiation date: Sep 2023 --> Apr 2024 | Trial primary completion date: Sep 2025 --> Apr 2026
- |||||||||| Trial completion date, Trial primary completion date: SARCOBEAGING: Sarcopenic Obesity as a Risk of Premature Aging (clinicaltrials.gov) - Mar 2, 2024
P=N/A, N=75, Active, not recruiting, Trial completion date: Sep 2025 --> Apr 2026 | Initiation date: Sep 2023 --> Apr 2024 | Trial primary completion date: Sep 2025 --> Apr 2026 Trial completion date: Mar 2024 --> Dec 2024 | Trial primary completion date: Dec 2023 --> Dec 2024
- |||||||||| Review, Journal: Obstacles to the Early Diagnosis and Management of Sarcopenia: Current Perspectives. (Pubmed Central) - Mar 1, 2024
In this article, we summarize current obstacles to early diagnosis and management of sarcopenia in clinical practice, and make recommendations to how these might be overcome. This includes our recommendation of incorporation of handgrip strength measurement into standard care, to enable dynamic assessment and identification of early declines in handgrip strength, so that interventions can be implemented to prevent disability.
- |||||||||| Journal: Research progress of relationship in long-novel coronavirus syndrome and sarcopenia (Pubmed Central) - Mar 1, 2024
However, at present, the scholars have not paid enough attention to the skeletal muscle weakness caused by the novel coronavirus. Therefore, this paper focuses on the long-novel coronavirus syndrome and sarcopenia to explore the pathological mechanism of skeletal muscle attenuation caused by the SARS-CoV-2 mediated "cytokine storm", mitochondrial damage, hypoxia state and other links,so as to raise the attention of clinical and academic researchers and improve the clinical strategy of frailty and sarcopenia after novel coronavirus infection.
- |||||||||| Review, Journal: Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis. (Pubmed Central) - Mar 1, 2024
This can be achieved by properly designed diets integrated with specific nutritional supplementations and accompanied by adequate physical exercise. Future studies aiming to add to the knowledge of the correct assessment and approach to sarcopenia in the context of NAFLD-related CLD are eagerly awaited.
- |||||||||| Journal: Nutrition Management in Geriatric Patients with Chronic Kidney Disease. (Pubmed Central) - Mar 1, 2024
Prevention of protein and energy depletion and replenishing the already low nutritional reserves elderly patients with CKD should focus on conventional and innovative strategies. This review aims to provide an overview of the mainstay of nutritional therapy in this patient population such as intake of adequate amounts of protein and energy along with along with preserving fluid, electrolyte, and mineral balance and to discuss more innovative interventions to aid these approaches.
- |||||||||| Review, Journal: Sarcopenic Obesity as a Risk Factor for Cardiovascular Disease: An Underrecognized Clinical Entity. (Pubmed Central) - Feb 29, 2024
However, numerous drugs and the role of bariatric surgery are still under trial, and have great scope for further research. This article covers the available literature regarding the definition, diagnostic criteria, and prevalence of SO, with available evidence linking it to CVD, metabolic disease and mortality, and an overview of current directives on management.
- |||||||||| Review, Journal: Cerebrovascular adaptations to habitual resistance exercise with aging. (Pubmed Central) - Feb 29, 2024
The purpose of this narrative review is to synthesize literature pertaining to cerebrovascular adaptations to RT at different stages of the life span. This review also aims to identify gaps in current understanding of long-term impacts of RT on cerebral hemodynamics and provide mechanistic rationale for these adaptations as they relate to aging, the cerebrovasculature and overall brain health.
- |||||||||| Journal: Is ChatGPT an Effective Tool for Providing Dietary Advice? (Pubmed Central) - Feb 28, 2024
However, when the chatbot handled overlapping conditions, limitations emerged, resulting in some contradictory or inappropriate advice. In conclusion, although ChatGPT exhibited a reasonable accuracy in providing general dietary advice for NCDs, its efficacy decreased in complex situations necessitating customized strategies; therefore, the chatbot is currently unable to replace a healthcare professional's consultation.
- |||||||||| Review, Journal: Immunogenetic Aspects of Sarcopenic Obesity. (Pubmed Central) - Feb 28, 2024
The lack of anti-inflammatory cytokine (e.g., IL-15) can increase SO risk, but further studies are needed to evaluate the exact mechanisms of implications of various cytokines in SO individuals. This manuscript analyses various immunogenetic and non-genetic factors and summarizes the recent findings on immunogenetics potentially impacting SO development.
- |||||||||| sirolimus / Generic mfg.
Review, Journal: Mitochondrial Quantity and Quality in Age-Related Sarcopenia. (Pubmed Central) - Feb 28, 2024 Several systems have been implicated in the regulation of muscle plasticity and trophism such as the fine-tuned and complex regulation between the stimulator of protein synthesis, mechanistic target of rapamycin (mTOR), and the inhibitor of mTOR, AMP-activated protein kinase (AMPK), that promotes muscle catabolism...We also discuss lifestyle interventions (i.e., physical exercise and nutrition) that may be exploited to preserve mitochondrial function in the aged muscle. Finally, we illustrate the emerging possibility of rescuing muscle tissue homeostasis through mitochondrial transplantation.
- |||||||||| Retrospective data, Journal: Dyslipidemia is associated with sarcopenia of the elderly: a meta-analysis. (Pubmed Central) - Feb 28, 2024
Finally, we illustrate the emerging possibility of rescuing muscle tissue homeostasis through mitochondrial transplantation. Dyslipidemia was associated with sarcopenia in the elderly, which was affected by sex, region and age.
|